The results obtained by Yang et al. also showed that casticin inhibited the Akt/mTOR and JAK2/STAT3 signaling pathways and reduced the glioma stem cells population by suppressing Oct4, Nanog, and Sox2. The gene discussed is AKT1; the disease is central nervous system cancer.